Bolt Biotherapeutics Net Income

Bolt Biotherapeutics (BOLT) currently reports a net income of $-29M as of June 2026. That compares with $-51M in the prior-year period — up 43.3% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore Bolt Biotherapeutics's net income history and peer comparisons.

Bolt Biotherapeutics's net income increased from $-51M to $-29M — a 43.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bolt Biotherapeutics's net income of $-29M is lower than the Healthcare sector average of $17B. That is roughly 100.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Bolt Biotherapeutics reported $-29M in net income as of June 2026. That compares with $-51M in the prior-year period — up 43.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-29M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for Bolt Biotherapeutics, and consider following BOLT for alerts when major investors trade the stock.